Compact, high-performance Infinite® F50 ELISA reader for demanding laboratories
Tecan's Infinite® F50 is an 8-channel absorbance microplate reader that redefines the standards of performance and compactness in the field of detection instruments. Designed to meet the needs of modern laboratories, it offers an ideal combination of speed, reliability and ease of use. Thanks to its innovative design and LED technology, the Infinite F50 enables accurate and reproducible measurements while reducing maintenance costs.
Its ultra-compact format, equivalent to the footprint of four microplates, allows for easy integration into any laboratory environment, optimising the space available on benches. This reader is particularly suitable for ELISA applications, offering endpoint, kinetic and multi-label measurements with consistent quality.
LED technology for lasting efficiency
One of the major advantages of the Infinite F50 is the use of LED technology to replace traditional halogen lamps. This innovation provides up to ten times longer life, eliminating the need for frequent lamp replacement and preheating wait times. In addition to its longevity, LED technology reduces energy consumption by 50% compared to conventional ELISA readers, contributing to a more environmentally friendly and economical approach.
The reliability of the system is proven by rigorous quality testing, with an MTTF (Mean Time to First Failure) value of over 100,000 plates, guaranteeing several years of optimal operation.
Powerful analysis and regulatory compliance with Magellan
The Infinite F50 is compatible with Magellan software, renowned for its powerful analysis and ease of use. This software enables comprehensive qualitative and quantitative analyses, with all types of regression curves (linear, non-linear, logit-log, polynomial, etc.) and quality control functions such as Levy-Jennings graphs.
Magellan is available in nine languages and offers tutorials and sample files to help you get started. As an option, Magellan Tracker software meets the requirements of regulated environments, with user management, electronic signatures and full traceability, in compliance with FDA 21 CFR Part 11 and European Directive 98/79/EC IVD-D.
